Global Pomalidomide Market Outlook 2022

SKU ID : QYR-19495217 | Publishing Date : 10-Nov-2021 | No. of pages : 119

Detailed TOC of Global Pomalidomide Market Outlook 2022

1 Pomalidomide Market Overview
    1.1 Product Overview and Scope of Pomalidomide
    1.2 Pomalidomide Segment by Type
        1.2.1 Global Pomalidomide Sales Growth Rate Comparison by Type (2021-2027)
        1.2.2 1mg Tables
        1.2.3 2mg Tables
        1.2.4 4mg Tables
    1.3 Pomalidomide Segment by Application
        1.3.1 Global Pomalidomide Sales Comparison by Application: (2021-2027)
        1.3.2 Hospital
        1.3.3 Drug Center
        1.3.4 Clinic
        1.3.5 Other
    1.4 Global Pomalidomide Market Size Estimates and Forecasts
        1.4.1 Global Pomalidomide Revenue 2016-2027
        1.4.2 Global Pomalidomide Sales 2016-2027
        1.4.3 Pomalidomide Market Size by Region: 2016 Versus 2021 Versus 2027

2 Pomalidomide Market Competition by Manufacturers
    2.1 Global Pomalidomide Sales Market Share by Manufacturers (2016-2021)
    2.2 Global Pomalidomide Revenue Market Share by Manufacturers (2016-2021)
    2.3 Global Pomalidomide Average Price by Manufacturers (2016-2021)
    2.4 Manufacturers Pomalidomide Manufacturing Sites, Area Served, Product Type
    2.5 Pomalidomide Market Competitive Situation and Trends
        2.5.1 Pomalidomide Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Pomalidomide Players Market Share by Revenue
        2.5.3 Global Pomalidomide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Pomalidomide Retrospective Market Scenario by Region
    3.1 Global Pomalidomide Retrospective Market Scenario in Sales by Region: 2016-2021
    3.2 Global Pomalidomide Retrospective Market Scenario in Revenue by Region: 2016-2021
    3.3 North America Pomalidomide Market Facts & Figures by Country
        3.3.1 North America Pomalidomide Sales by Country
        3.3.2 North America Pomalidomide Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Pomalidomide Market Facts & Figures by Country
        3.4.1 Europe Pomalidomide Sales by Country
        3.4.2 Europe Pomalidomide Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Pomalidomide Market Facts & Figures by Region
        3.5.1 Asia Pacific Pomalidomide Sales by Region
        3.5.2 Asia Pacific Pomalidomide Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Pomalidomide Market Facts & Figures by Country
        3.6.1 Latin America Pomalidomide Sales by Country
        3.6.2 Latin America Pomalidomide Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Pomalidomide Market Facts & Figures by Country
        3.7.1 Middle East and Africa Pomalidomide Sales by Country
        3.7.2 Middle East and Africa Pomalidomide Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Pomalidomide Historic Market Analysis by Type
    4.1 Global Pomalidomide Sales Market Share by Type (2016-2021)
    4.2 Global Pomalidomide Revenue Market Share by Type (2016-2021)
    4.3 Global Pomalidomide Price by Type (2016-2021)

5 Global Pomalidomide Historic Market Analysis by Application
    5.1 Global Pomalidomide Sales Market Share by Application (2016-2021)
    5.2 Global Pomalidomide Revenue Market Share by Application (2016-2021)
    5.3 Global Pomalidomide Price by Application (2016-2021)

6 Key Companies Profiled
    6.1 Celgene
        6.1.1 Celgene Corporation Information
        6.1.2 Celgene Description and Business Overview
        6.1.3 Celgene Pomalidomide Sales, Revenue and Gross Margin (2016-2021)
        6.1.4 Celgene Pomalidomide Product Portfolio
        6.1.5 Celgene Recent Developments/Updates
    6.2 Natco Pharma
        6.2.1 Natco Pharma Corporation Information
        6.2.2 Natco Pharma Description and Business Overview
        6.2.3 Natco Pharma Pomalidomide Sales, Revenue and Gross Margin (2016-2021)
        6.2.4 Natco Pharma Pomalidomide Product Portfolio
        6.2.5 Natco Pharma Recent Developments/Updates
    6.3 Intas Pharmaceuticals
        6.3.1 Intas Pharmaceuticals Corporation Information
        6.3.2 Intas Pharmaceuticals Description and Business Overview
        6.3.3 Intas Pharmaceuticals Pomalidomide Sales, Revenue and Gross Margin (2016-2021)
        6.3.4 Intas Pharmaceuticals Pomalidomide Product Portfolio
        6.3.5 Intas Pharmaceuticals Recent Developments/Updates
    6.4 Indiabulls Pharmaceutical
        6.4.1 Indiabulls Pharmaceutical Corporation Information
        6.4.2 Indiabulls Pharmaceutical Description and Business Overview
        6.4.3 Indiabulls Pharmaceutical Pomalidomide Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Indiabulls Pharmaceutical Pomalidomide Product Portfolio
        6.4.5 Indiabulls Pharmaceutical Recent Developments/Updates
    6.5 Cipla
        6.5.1 Cipla Corporation Information
        6.5.2 Cipla Description and Business Overview
        6.5.3 Cipla Pomalidomide Sales, Revenue and Gross Margin (2016-2021)
        6.5.4 Cipla Pomalidomide Product Portfolio
        6.5.5 Cipla Recent Developments/Updates
    6.6 Glenmark Pharmaceuticals
        6.6.1 Glenmark Pharmaceuticals Corporation Information
        6.6.2 Glenmark Pharmaceuticals Description and Business Overview
        6.6.3 Glenmark Pharmaceuticals Pomalidomide Sales, Revenue and Gross Margin (2016-2021)
        6.6.4 Glenmark Pharmaceuticals Pomalidomide Product Portfolio
        6.6.5 Glenmark Pharmaceuticals Recent Developments/Updates
    6.7 Dr Reddy's Laboratories
        6.6.1 Dr Reddy's Laboratories Corporation Information
        6.6.2 Dr Reddy's Laboratories Description and Business Overview
        6.6.3 Dr Reddy's Laboratories Pomalidomide Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Dr Reddy's Laboratories Pomalidomide Product Portfolio
        6.7.5 Dr Reddy's Laboratories Recent Developments/Updates
    6.8 Qilu Pharmaceutical
        6.8.1 Qilu Pharmaceutical Corporation Information
        6.8.2 Qilu Pharmaceutical Description and Business Overview
        6.8.3 Qilu Pharmaceutical Pomalidomide Sales, Revenue and Gross Margin (2016-2021)
        6.8.4 Qilu Pharmaceutical Pomalidomide Product Portfolio
        6.8.5 Qilu Pharmaceutical Recent Developments/Updates
    6.9 Chia Tai-Tianqing
        6.9.1 Chia Tai-Tianqing Corporation Information
        6.9.2 Chia Tai-Tianqing Description and Business Overview
        6.9.3 Chia Tai-Tianqing Pomalidomide Sales, Revenue and Gross Margin (2016-2021)
        6.9.4 Chia Tai-Tianqing Pomalidomide Product Portfolio
        6.9.5 Chia Tai-Tianqing Recent Developments/Updates
    6.10 Hanson Pharm
        6.10.1 Hanson Pharm Corporation Information
        6.10.2 Hanson Pharm Description and Business Overview
        6.10.3 Hanson Pharm Pomalidomide Sales, Revenue and Gross Margin (2016-2021)
        6.10.4 Hanson Pharm Pomalidomide Product Portfolio
        6.10.5 Hanson Pharm Recent Developments/Updates
    6.11 Meidakang Huakang Pharmaceutical
        6.11.1 Meidakang Huakang Pharmaceutical Corporation Information
        6.11.2 Meidakang Huakang Pharmaceutical Pomalidomide Description and Business Overview
        6.11.3 Meidakang Huakang Pharmaceutical Pomalidomide Sales, Revenue and Gross Margin (2016-2021)
        6.11.4 Meidakang Huakang Pharmaceutical Pomalidomide Product Portfolio
        6.11.5 Meidakang Huakang Pharmaceutical Recent Developments/Updates
    6.12 Shandong Kongfu Pharmaceutical
        6.12.1 Shandong Kongfu Pharmaceutical Corporation Information
        6.12.2 Shandong Kongfu Pharmaceutical Pomalidomide Description and Business Overview
        6.12.3 Shandong Kongfu Pharmaceutical Pomalidomide Sales, Revenue and Gross Margin (2016-2021)
        6.12.4 Shandong Kongfu Pharmaceutical Pomalidomide Product Portfolio
        6.12.5 Shandong Kongfu Pharmaceutical Recent Developments/Updates
    6.13 SL PHARM
        6.13.1 SL PHARM Corporation Information
        6.13.2 SL PHARM Pomalidomide Description and Business Overview
        6.13.3 SL PHARM Pomalidomide Sales, Revenue and Gross Margin (2016-2021)
        6.13.4 SL PHARM Pomalidomide Product Portfolio
        6.13.5 SL PHARM Recent Developments/Updates

7 Pomalidomide Manufacturing Cost Analysis
    7.1 Pomalidomide Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Pomalidomide
    7.4 Pomalidomide Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Pomalidomide Distributors List
    8.3 Pomalidomide Customers

9 Pomalidomide Market Dynamics
    9.1 Pomalidomide Industry Trends
    9.2 Pomalidomide Growth Drivers
    9.3 Pomalidomide Market Challenges
    9.4 Pomalidomide Market Restraints

10 Global Market Forecast
    10.1 Pomalidomide Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Pomalidomide by Type (2022-2027)
        10.1.2 Global Forecasted Revenue of Pomalidomide by Type (2022-2027)
    10.2 Pomalidomide Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Pomalidomide by Application (2022-2027)
        10.2.2 Global Forecasted Revenue of Pomalidomide by Application (2022-2027)
    10.3 Pomalidomide Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Pomalidomide by Region (2022-2027)
        10.3.2 Global Forecasted Revenue of Pomalidomide by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Figures, Tables and Charts Available in Global Pomalidomide Market Outlook 2022

List of Tables
    Table 1. Global Pomalidomide Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
    Table 2. Global Pomalidomide Sales (K Pcs) Comparison by Application (2021-2027)
    Table 3. Global Pomalidomide Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
    Table 4. Key Manufacturers Pomalidomide Covered in This Study
    Table 5. Global Pomalidomide Sales (K Pcs) of Key Manufacturers (2016-2021)
    Table 6. Global Pomalidomide Sales Market Share by Manufacturers (2016-2021)
    Table 7. Global Pomalidomide Revenue (US$ Million) by Manufacturers (2016-2021)
    Table 8. Global Pomalidomide Revenue Share by Manufacturers (2016-2021)
    Table 9. Global Market Pomalidomide Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
    Table 10. Manufacturers Pomalidomide Manufacturing Sites and Area Served
    Table 11. Manufacturers Pomalidomide Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Pomalidomide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pomalidomide as of 2020)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Pomalidomide Sales by Region (2016-2021) & (K Pcs)
    Table 16. Global Pomalidomide Sales Market Share by Region (2016-2021)
    Table 17. Global Pomalidomide Revenue by Region (2016-2021) & (US$ Million)
    Table 18. North America Pomalidomide Sales by Country (2016-2021) & (K Pcs)
    Table 19. North America Pomalidomide Sales Market Share by Country (2016-2021)
    Table 20. North America Pomalidomide Revenue by Country (2016-2021) & (US$ Million)
    Table 21. North America Pomalidomide Revenue Market Share by Country (2016-2021)
    Table 22. Europe Pomalidomide Sales by Country (2016-2021) & (K Pcs)
    Table 23. Europe Pomalidomide Sales Market Share by Country (2016-2021)
    Table 24. Europe Pomalidomide Revenue by Country (2016-2021) & (US$ Million)
    Table 25. Europe Pomalidomide Revenue Market Share by Country (2016-2021)
    Table 26. Asia Pacific Pomalidomide Sales by Region (2016-2021) & (K Pcs)
    Table 27. Asia Pacific Pomalidomide Sales Market Share by Region (2016-2021)
    Table 28. Asia Pacific Pomalidomide Revenue by Region (2016-2021) & (US$ Million)
    Table 29. Asia Pacific Pomalidomide Revenue Market Share by Region (2016-2021)
    Table 30. Latin America Pomalidomide Sales by Country (2016-2021) & (K Pcs)
    Table 31. Latin America Pomalidomide Sales Market Share by Country (2016-2021)
    Table 32. Latin America Pomalidomide Revenue by Country (2016-2021) & (US$ Million)
    Table 33. Latin America Pomalidomide Revenue Market Share by Country (2016-2021)
    Table 34. Middle East and Africa Pomalidomide Sales by Country (2016-2021) & (K Pcs)
    Table 35. Middle East and Africa Pomalidomide Sales Market Share by Country (2016-2021)
    Table 36. Middle East and Africa Pomalidomide Revenue by Country (2016-2021) & (US$ Million)
    Table 37. Middle East and Africa Pomalidomide Revenue Market Share by Country (2016-2021)
    Table 38. Global Pomalidomide Sales (K Pcs) by Type (2016-2021)
    Table 39. Global Pomalidomide Sales Market Share by Type (2016-2021)
    Table 40. Global Pomalidomide Revenue (Million US$) by Type (2016-2021)
    Table 41. Global Pomalidomide Revenue Share by Type (2016-2021)
    Table 42. Global Pomalidomide Price (USD/Pcs) by Type (2016-2021)
    Table 43. Global Pomalidomide Sales (K Pcs) by Application (2016-2021)
    Table 44. Global Pomalidomide Sales Market Share by Application (2016-2021)
    Table 45. Global Pomalidomide Revenue (Million US$) by Application (2016-2021)
    Table 46. Global Pomalidomide Revenue Share by Application (2016-2021)
    Table 47. Global Pomalidomide Price (USD/Pcs) by Application (2016-2021)
    Table 48. Celgene Corporation Information
    Table 49. Celgene Description and Business Overview
    Table 50. Celgene Pomalidomide Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 51. Celgene Pomalidomide Product
    Table 52. Celgene Recent Developments/Updates
    Table 53. Natco Pharma Corporation Information
    Table 54. Natco Pharma Description and Business Overview
    Table 55. Natco Pharma Pomalidomide Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 56. Natco Pharma Pomalidomide Product
    Table 57. Natco Pharma Recent Developments/Updates
    Table 58. Intas Pharmaceuticals Corporation Information
    Table 59. Intas Pharmaceuticals Description and Business Overview
    Table 60. Intas Pharmaceuticals Pomalidomide Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 61. Intas Pharmaceuticals Pomalidomide Product
    Table 62. Intas Pharmaceuticals Recent Developments/Updates
    Table 63. Indiabulls Pharmaceutical Corporation Information
    Table 64. Indiabulls Pharmaceutical Description and Business Overview
    Table 65. Indiabulls Pharmaceutical Pomalidomide Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 66. Indiabulls Pharmaceutical Pomalidomide Product
    Table 67. Indiabulls Pharmaceutical Recent Developments/Updates
    Table 68. Cipla Corporation Information
    Table 69. Cipla Description and Business Overview
    Table 70. Cipla Pomalidomide Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 71. Cipla Pomalidomide Product
    Table 72. Cipla Recent Developments/Updates
    Table 73. Glenmark Pharmaceuticals Corporation Information
    Table 74. Glenmark Pharmaceuticals Description and Business Overview
    Table 75. Glenmark Pharmaceuticals Pomalidomide Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 76. Glenmark Pharmaceuticals Pomalidomide Product
    Table 77. Glenmark Pharmaceuticals Recent Developments/Updates
    Table 78. Dr Reddy's Laboratories Corporation Information
    Table 79. Dr Reddy's Laboratories Description and Business Overview
    Table 80. Dr Reddy's Laboratories Pomalidomide Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 81. Dr Reddy's Laboratories Pomalidomide Product
    Table 82. Dr Reddy's Laboratories Recent Developments/Updates
    Table 83. Qilu Pharmaceutical Corporation Information
    Table 84. Qilu Pharmaceutical Description and Business Overview
    Table 85. Qilu Pharmaceutical Pomalidomide Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 86. Qilu Pharmaceutical Pomalidomide Product
    Table 87. Qilu Pharmaceutical Recent Developments/Updates
    Table 88. Chia Tai-Tianqing Corporation Information
    Table 89. Chia Tai-Tianqing Description and Business Overview
    Table 90. Chia Tai-Tianqing Pomalidomide Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 91. Chia Tai-Tianqing Pomalidomide Product
    Table 92. Chia Tai-Tianqing Recent Developments/Updates
    Table 93. Hanson Pharm Corporation Information
    Table 94. Hanson Pharm Description and Business Overview
    Table 95. Hanson Pharm Pomalidomide Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 96. Hanson Pharm Pomalidomide Product
    Table 97. Hanson Pharm Recent Developments/Updates
    Table 98. Meidakang Huakang Pharmaceutical Corporation Information
    Table 99. Meidakang Huakang Pharmaceutical Description and Business Overview
    Table 100. Meidakang Huakang Pharmaceutical Pomalidomide Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 101. Meidakang Huakang Pharmaceutical Pomalidomide Product
    Table 102. Meidakang Huakang Pharmaceutical Recent Developments/Updates
    Table 103. Shandong Kongfu Pharmaceutical Corporation Information
    Table 104. Shandong Kongfu Pharmaceutical Description and Business Overview
    Table 105. Shandong Kongfu Pharmaceutical Pomalidomide Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 106. Shandong Kongfu Pharmaceutical Pomalidomide Product
    Table 107. Shandong Kongfu Pharmaceutical Recent Developments/Updates
    Table 108. SL PHARM Corporation Information
    Table 109. SL PHARM Description and Business Overview
    Table 110. SL PHARM Pomalidomide Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 111. SL PHARM Pomalidomide Product
    Table 112. SL PHARM Recent Developments/Updates
    Table 113. Production Base and Market Concentration Rate of Raw Material
    Table 114. Key Suppliers of Raw Materials
    Table 115. Pomalidomide Distributors List
    Table 116. Pomalidomide Customers List
    Table 117. Pomalidomide Market Trends
    Table 118. Pomalidomide Growth Drivers
    Table 119. Pomalidomide Market Challenges
    Table 120. Pomalidomide Market Restraints
    Table 121. Global Pomalidomide Sales Forecast by Type (2022-2027) & (K Pcs)
    Table 122. Global Pomalidomide Sales Market Share Forecast by Type (2022-2027)
    Table 123. Global Pomalidomide Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 124. Global Pomalidomide Revenue Market Share Forecast by Type (2022-2027)
    Table 125. Global Pomalidomide Sales Forecast by Application (2022-2027) & (K Pcs)
    Table 126. Global Pomalidomide Sales Market Share Forecast by Application (2022-2027)
    Table 127. Global Pomalidomide Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 128. Global Pomalidomide Revenue Market Share Forecast by Application (2022-2027)
    Table 129. Global Pomalidomide Sales Forecast by Region (2022-2027) & (K Pcs)
    Table 130. Global Pomalidomide Sales Market Share Forecast by Region (2022-2027)
    Table 131. Global Pomalidomide Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 132. Global Pomalidomide Revenue Market Share Forecast by Region (2022-2027)
    Table 133. Research Programs/Design for This Report
    Table 134. Key Data Information from Secondary Sources
    Table 135. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Pomalidomide
    Figure 2. Global Pomalidomide Market Share by Type in 2020 & 2027
    Figure 3. 1mg Tables Product Picture
    Figure 4. 2mg Tables Product Picture
    Figure 5. 4mg Tables Product Picture
    Figure 6. Global Pomalidomide Market Share by Application in 2020 & 2027
    Figure 7. Hospital
    Figure 8. Drug Center
    Figure 9. Clinic
    Figure 10. Other
    Figure 11. Global Pomalidomide Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Pomalidomide Market Size 2016-2027 (US$ Million)
    Figure 13. Global Pomalidomide Sales 2016-2027 (K Pcs)
    Figure 14. Global Pomalidomide Market Size Market Share by Region: 2016 VS 20210 VS 2027
    Figure 15. Pomalidomide Sales Share by Manufacturers in 2020
    Figure 16. Global Pomalidomide Revenue Share by Manufacturers in 2020
    Figure 17. The Global 5 and 10 Largest Pomalidomide Players: Market Share by Revenue in 2020
    Figure 18. Pomalidomide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
    Figure 19. Global Pomalidomide Sales Market Share by Region (2016-2021)
    Figure 20. Global Pomalidomide Sales Market Share by Region in 2020
    Figure 21. Global Pomalidomide Revenue Market Share by Region (2016-2021)
    Figure 22. Global Pomalidomide Revenue Market Share by Region in 2020
    Figure 23. U.S. Pomalidomide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 24. Canada Pomalidomide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 25. Germany Pomalidomide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 26. France Pomalidomide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 27. U.K. Pomalidomide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 28. Italy Pomalidomide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 29. Russia Pomalidomide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 30. China Pomalidomide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 31. Japan Pomalidomide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 32. South Korea Pomalidomide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 33. India Pomalidomide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 34. Australia Pomalidomide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 35. Taiwan Pomalidomide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 36. Indonesia Pomalidomide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 37. Thailand Pomalidomide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 38. Malaysia Pomalidomide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 39. Philippines Pomalidomide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 40. Vietnam Pomalidomide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 41. Mexico Pomalidomide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 42. Brazil Pomalidomide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 43. Argentina Pomalidomide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 44. Turkey Pomalidomide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 45. Saudi Arabia Pomalidomide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 46. U.A.E Pomalidomide Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 47. Sales Market Share of Pomalidomide by Type (2016-2021)
    Figure 48. Sales Market Share of Pomalidomide by Application (2016-2021)
    Figure 49. Sales Market Share of Pomalidomide by Application in 2020
    Figure 50. Revenue Share of Pomalidomide by Application (2016-2021)
    Figure 51. Revenue Share of Pomalidomide by Application in 2020
    Figure 52. Manufacturing Cost Structure of Pomalidomide
    Figure 53. Manufacturing Process Analysis of Pomalidomide
    Figure 54. Pomalidomide Industrial Chain Analysis
    Figure 55. Channels of Distribution
    Figure 56. Distributors Profiles
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed

Keyplayers in Global Pomalidomide Market Outlook 2022

Celgene
Natco Pharma
Intas Pharmaceuticals
Indiabulls Pharmaceutical
Cipla
Glenmark Pharmaceuticals
Dr Reddy's Laboratories
Qilu Pharmaceutical
Chia Tai-Tianqing
Hanson Pharm
Meidakang Huakang Pharmaceutical
Shandong Kongfu Pharmaceutical
SL PHARM